CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 9 filers reported holding CHINA PHARMA HLDGS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $45,000 | -54.5% | 286,493 | -42.3% | 0.01% | -50.0% |
| Q3 2015 | $99,000 | -44.7% | 496,785 | 0.0% | 0.03% | -35.0% |
| Q2 2015 | $179,000 | -15.2% | 496,785 | -20.0% | 0.04% | -7.0% |
| Q1 2015 | $211,000 | -45.5% | 621,135 | -51.9% | 0.04% | -37.7% |
| Q4 2014 | $387,000 | +12.2% | 1,290,463 | -6.3% | 0.07% | +11.3% |
| Q3 2014 | $345,000 | -36.0% | 1,376,496 | -1.6% | 0.06% | -26.2% |
| Q2 2014 | $539,000 | -24.9% | 1,399,396 | -1.6% | 0.08% | -25.0% |
| Q1 2014 | $718,000 | +40.5% | 1,421,596 | -4.0% | 0.11% | +41.8% |
| Q4 2013 | $511,000 | +18.3% | 1,480,434 | -4.0% | 0.08% | +12.9% |
| Q3 2013 | $432,000 | +35.8% | 1,542,621 | +1.9% | 0.07% | +29.6% |
| Q2 2013 | $318,000 | – | 1,514,422 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HRT FINANCIAL LP | 150,355 | $54,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 235,000 | $86,000 | 0.00% |
| UBS Group AG | 48,018 | $18,000 | 0.00% |
| Citadel Advisors | 98,530 | $36,000 | 0.00% |
| Renaissance Technologies | 728,580 | $266,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |